- Home
- FULC vs PHT Comparison
FULC vs PHT Comparison
Compare FULC & PHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- PHT
- Stock Information
- Founded
- FULC 2015
- PHT 2002
- Country
- FULC United States
- PHT United States
- Employees
- FULC N/A
- PHT N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- PHT Investment Managers
- Sector
- FULC Health Care
- PHT Finance
- Exchange
- FULC Nasdaq
- PHT Nasdaq
- Market Cap
- FULC 221.5M
- PHT 230.3M
- IPO Year
- FULC 2019
- PHT N/A
- Fundamental
- Price
- FULC $3.64
- PHT $7.84
- Analyst Decision
- FULC Hold
- PHT
- Analyst Count
- FULC 10
- PHT 0
- Target Price
- FULC $7.44
- PHT N/A
- AVG Volume (30 Days)
- FULC 676.6K
- PHT 85.5K
- Earning Date
- FULC 11-13-2024
- PHT 01-01-0001
- Dividend Yield
- FULC N/A
- PHT 8.76%
- EPS Growth
- FULC N/A
- PHT N/A
- EPS
- FULC N/A
- PHT 0.98
- Revenue
- FULC $81,630,000.00
- PHT N/A
- Revenue This Year
- FULC $2,821.96
- PHT N/A
- Revenue Next Year
- FULC N/A
- PHT N/A
- P/E Ratio
- FULC N/A
- PHT $7.71
- Revenue Growth
- FULC 2582.55
- PHT N/A
- 52 Week Low
- FULC $2.87
- PHT $6.41
- 52 Week High
- FULC $13.70
- PHT $7.60
- Technical
- Relative Strength Index (RSI)
- FULC 50.49
- PHT 64.36
- Support Level
- FULC $3.38
- PHT $7.73
- Resistance Level
- FULC $3.63
- PHT $8.00
- Average True Range (ATR)
- FULC 0.16
- PHT 0.06
- MACD
- FULC 0.12
- PHT 0.03
- Stochastic Oscillator
- FULC 87.18
- PHT 93.07
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About PHT Pioneer High Income Fund Inc.
Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.